Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2009 | 12-2008 | 06-2008 | 12-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | N/A | 0 | N/A | -1,410 |
| Depreciation Amortization | 0 | N/A | 0 | N/A | 1,450 |
| Other Working Capital | 0 | N/A | 0 | N/A | 780 |
| Other Operating Activity | -3,740 | 0 | 370 | 0 | 1,040 |
| Operating Cash Flow | $-3,740 | $N/A | $370 | $N/A | $1,860 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 90 | N/A | -40 | N/A | -130 |
| Net Acquisitions | -360 | N/A | 0 | N/A | 0 |
| Other Investing Activity | 10 | 0 | 0 | 0 | 270 |
| Investing Cash Flow | $-260 | $N/A | $-40 | $N/A | $140 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -140 | 0 | -700 | 0 | -390 |
| Financing Cash Flow | $-140 | $N/A | $-700 | $N/A | $-390 |
| Exchange Rate Effect | -50 | N/A | 0 | N/A | 1,050 |
| Beginning Cash Position | 10,160 | N/A | 12,350 | N/A | 7,900 |
| End Cash Position | 5,940 | N/A | 11,980 | N/A | 10,560 |
| Net Cash Flow | $-4,210 | $N/A | $-370 | $N/A | $2,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,740 | N/A | 370 | N/A | 1,860 |
| Free Cash Flow | -3,740 | 0 | 370 | 0 | 1,860 |